Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

£13m funding boost announced for Northern Irish pharmacies

This funding for community pharmacy in Northern Ireland is in addition to existing funding and will be available until March 2021, health minister Robin Swann said yesterday.

Pharmacies in Northern Ireland will receive the £13.25 million on top of the “recurring financial envelope” of £112.4m for 2020/21. This adds to a £10.5m funding boost announced in March, of which £4m fell into the 2019/20 financial year, and £6.5m into the 2020/21 financial year. A further £1m for the sector was provided in April, to cover costs including Easter rotas.  

The funding, announced yesterday (July 1) will ensure that – along with core dispensing duties – community pharmacies can start to provide additional services to “meet the needs of patients during the pandemic period” from this month, the Department of Health in Northern Ireland (DoH) said.

These include the continuation of the emergency supply service, which started in “phase one of the pandemic” and the reinstatement of smoking cessation and opiate dependence services, which were put on hold at the start of the COVID-19 pandemic.

Additionally, an “enhanced on-call palliative care service will be provided and a new service developed for care homes”, the DoH said.

Pharmacies will also provide “targeted advice and signposting for mental and physical health promotion”, and offer consultations with a pharmacist for input and treatment for common conditions as part of a “pharmacy first” initiative – similar to the Pharmacy First initiative in Scotland

Finally, a medicines delivery service will be developed for vulnerable patients.

"Historical challenges"

Mr Swann said he was  “very pleased to be able to announce this investment in community pharmacy, which has responded promptly and professionally to the COVID-19 emergency response”.

“I fully understand the historical challenges faced by the sector. This agreement provides a firm foundation that will enable community pharmacy to play a full part in the future of health and social care,” he added.

“This is the first time that an agreement on the commissioning and funding of community pharmacy has been reached in Northern Ireland and I recognise all the hard work that has brought us here today,” Mr Swann said.

Funding is move towards the future

Cathy Harrison, chief pharmaceutical officer for Northern Ireland, said the funding package shows that the government is “backing” community pharmacy teams as it continues to work through the “uncertainty of the coming months and towards a more positive future.”

Gerard Greene, chief executive of Community Pharmacy Northern Ireland said the organisation “welcomes the announcement”, and that the funding “signals a move forward for community pharmacy as a key service in the new post-COVID  health and social care system, supporting important service provision to patients”.

“It is a clear recognition of the critical role of the sector, not only in the safe supply of medicines but as the fabric that holds local communities together in times of crisis,” Mr Greene added.

What do you make of the funding agreement?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD006581

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel